FDA Authorizes First Tests To Quantify Coronavirus Antibodies

Click the image below to enlarge the infographic.
  • The US Food and Drug Administration (FDA) authorized the first two COVID-19 serology tests to quantify antibodies present in the blood of recovered coronavirus patients
  • Both tests, developed by Siemens, do not give a precise measurement of coronavirus antibodies but an estimate
  • When one gets infected with coronavirus, the body mounts up an immune response that results in a surge of immune cells to the infection site
  • FDA officials say having an estimate of the amount of immune cells triggered in response to the virus may help scientists better understand immunity to the infection
  • They warn, however, that those whose test reveals significant immune response to the virus should not stop taking preventive measures against a re-infection